Brak połączenia z internetem — wyświetlanie zapisanej wersji strony.

Tevogen Bio Holdi…

USUSD
← Do Screenera

Tevogen Bio Holdings Inc. (US:TVGN) — Biotechnology: Biological Products (No Diagnostic Substances). Liczba giełd, na których notowane są akcje spółki: 1. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.

O Firmie

Strona
tevogen.com
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siedziba
WARREN, United States
Prezes
Ryan H. Saadi
Pracownicy
18
Akcje w Obrocie
6.51 mln na 2026-08-10
Free Float
843 310
Kapitalizacja Rynkowa
45.45 mln USD
Insiderzy
72.08%
Inwestorzy Instytucjonalni
1.65%
Branża (SIC)
Biological Products, (No Diagnostic Substances)
FCF
−12.4 mln USD
Dług
1.01 mln USD
Zyski i FCF — za 12 miesięcy do 30.06.2026 roku (najnowszy raport firmy).
Opis

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.

Giełdy i Tickery

GiełdaTickerWalutaCenaTyp
US USA StocksTVGNUSD6.78 -3.97%akcje zwykłe

Cena z 3 Miesięcy

US:TVGN · USD
dzień wzrostu dzień spadkuNajedź / dotknij dnia — ceny otwarcia, zamknięcia, najwyższa i najniższa
reklama

Najwięksi Akcjonariusze

PosiadaczUdziałAkcjeData Raportu
KHAN SADIQ (Officer)≈17.96%1.17 mln2025-06-27
DESAI KIRTI (Chief Finan…≈15.25%992 9832026-09-14
PATTON CURTIS L (Directo…≈2.14%139 1922026-09-11
FEIKE JEFFREY L (Directo…≈2.02%131 4352026-09-11
SORDILLO VICTOR J (Direc…≈1.94%126 5392026-09-11
GOH KEOW LIN (Director)≈1.9%123 6782026-09-11
PODLOGAR SUSAN M (Direct…≈1.9%123 6782026-09-11
FLOMENBERG NEAL (Officer…≈1.18%76 9402026-03-13
Vanguard Capital Managem…0.15%23 9762026-06-30
Morgan Stanley0.12%18 8092026-06-30
AQR Capital Management,…0.11%17 2372026-06-30
VANGUARD INDEX FUNDS-Van…0.1%15 1022026-06-30
Goldman Sachs Group Inc0.09%14 1632026-06-30
GOLDMAN SACHS TRUST-Gold…0.09%13 9512026-06-30
Jane Street Group, LLC0.07%11 1752026-06-30
FMR, LLC0.06%9 8262026-06-30
VANGUARD Inst. INDEX Fd.…0.04%7 0352026-06-30
Russell Investments Grou…0.04%6 5322026-06-30
Fidelity Concord Street…0.03%4 0812026-07-31
VANGUARD SCOTTSDALE FUND…0.03%4 0532026-05-31
VANGUARD INDEX FUNDS-Van…0.01%1 8392026-06-30
Tower Research Capital L…0.01%1 4942026-06-30
Fidelity Concord Street…0.01%1 4632026-07-31
UBS Group AG0.01%1 0832026-06-30
Vanguard Fiduciary Trust…0.01%8382026-06-30
Fidelity Concord Street…0%3572026-07-31
VANGUARD SCOTTSDALE FUND…0%3142026-05-31
Fidelity Concord Street…0%3002026-07-31
SAADI RYAN H (Chief Exec…—11.71 mln2026-09-14